HKSE Healthcare Medical - Devices 1858.HK

Beijing Chunlizhengda Medical Instruments Co., Ltd.

$ 8.81 0.11 %

Beijing Chunlizhengda Medical Instruments Co., Ltd. functions as a prominent entity within the orthopedic medical device industry, dedicated to the development, manufacturing, and distribution of surgical implants, instruments, and associated medical supplies throughout the People's Republic of China. Its core product range features implantable orthopedic solutions, specifically comprising joint prostheses and spinal treatment products. The company predominantly distributes its merchandise via an expansive network of distributors, through original design manufacturing (ODM) and original equipment manufacturing (OEM) partnerships under the 'Chunli' label, and by direct sales to healthcare institutions. Beyond its domestic operations, the firm also engages in exporting its products to various countries globally. Established in 1998, its corporate headquarters are situated in Beijing, China.

CEO: Wenling Shi - https://www.clzd.com

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

-

Recommandation

-

DCF

$ 17.03

Loading data...

1858.HK vs S&P500

Loading data...

No data available.

Quick ratio

4.98

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

10.74

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

0.82

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

9.25 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

8.64 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

5.17

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.00

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

1.09

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

65.00 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
7 indicates good financial health
Altman score
6.57 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
2.65 indicates that the company has sufficient cash to cover its short-term debts
Debt Ratio
0.00 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.